Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects.
Lee S, Lee Y, Kim AH, Yoon S, Lee J, Ji SC, Yoon SH, Lee S, Yu KS, Jang IJ, Cho JY.
Lee S, et al. Among authors: lee y, lee j.
Drug Metab Pharmacokinet. 2021 Feb;36:100374. doi: 10.1016/j.dmpk.2020.12.001. Epub 2020 Dec 3.
Drug Metab Pharmacokinet. 2021.
PMID: 33348239
Clinical Trial.